Dr Anna Moltó
Dr Anna Moltó is an attending rheumatologist in the Rheumatology Department of Cochin Hospital, Paris, France, and also acts as a clinical researcher in the INSERM ECAMO team (U-1153) from the University of Paris, France.
She completed both her medical studies and rheumatology training at Universitat Autónoma de Barcelona, Spain, in 2010. She completed a clinical research fellowship in Paris, and in 2011, was an assistant professor at Cochin Hospital. Dr Moltó was co-opted by Emerging EULAR Network (EMEUNET) in 2010, where she first served as part of the Country Liaisons subgroup, subsequently as its leader. She was elected Chair of EMEUNET in 2015.
Dr Moltó’s research focuses mainly on the natural history of early axial spondyloarthritis, evaluation of effectiveness in observational trials and pregnancy outcomes in patients with inflammatory rheumatic diseases. She has authored more than 100 peer-reviewed publications.
Exploring how the guidelines defines holistic care
Integrating holistic care through guideline recommendations with patient-reported outcomes and shared decision-making
Personalising the approach to HS care
Personalised HS care: Addressing the multi-faceted burden of HS with a case study example
Combination approaches in HS
The role of combined medical/surgical and medical-only treatments, including the optimal time for intervention
An overview of the European S2k guidelines
Key guideline updates including management algorithms for inflammatory and non-inflammatory HS phenotypes
Shared decisions: Redefining HS treatment
Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care
From guidelines to action: Transforming HS treatment pathways
Dr van der Zee and Prof. Arenbergerová explore holistic treatment of HS through medical, surgical and combined approaches